Javier Serrano-Delgado
Sevilla, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Impact of inotuzumab ozogamicin as bridging therapy and tumor burden in CAR-T therapy for B-acute lymphoblastic leukemia.
Journal: Frontiers in immunology
Published: October 15, 2025
Temporal dynamics of substance P and its association with cytokine release syndrome after CD19 CAR-T therapy in pediatric B-ALL.
Journal: Stem cell research & therapy
Published: October 14, 2025
Varnimcabtagene autoleucel for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia in Spain (CART19-BE-02): a multicentre, single-arm, phase 2 trial.
Journal: The Lancet. Haematology
Published: October 06, 2025
Ixazomib decreases the risk of chronic graft-versus-host disease: identification of cGVHD biomarkers.
Journal: Blood advances
Published: February 25, 2025
Site-specific analysis of extranodal involvement in large B-cell lymphoma reveals distinct efficacy with chimeric antigen receptor T-cell therapy.
Journal: Leukemia
Published: January 11, 2025
Corrigendum: Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring.
Journal: Frontiers in immunology
Published: January 20, 2024
Recent Bendamustine Treatment Before Apheresis Has a Negative Impact on Outcomes in Patients With Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 24, 2023
Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring.
Journal: Frontiers in immunology
Published: August 20, 2023
Monitoring of kinetics and exhaustion markers of circulating CAR-T cells as early predictive factors in patients with B-cell malignancies.
Journal: Frontiers in immunology
Published: January 27, 2023
Best Treatment Option for Patients With Refractory Aggressive B-Cell Lymphoma in the CAR-T Cell Era: Real-World Evidence From GELTAMO/GETH Spanish Groups.
Journal: Frontiers in immunology
Published: January 15, 2022
Eosinophils engulfing platelets and with ring-shaped nuclei in nivolumab-associated eosinophilia.
Journal: British journal of haematology
Published: September 14, 2019
Showing 1-12 of 12
Last Updated: 09/26/2026